It's curious to watch on TV, or to read, people pontificating in tedious academese on subjects they don't understand but have been funded to talk or write about. The general rule is that, so long as fundamental questions aren't asked, any drivel will do provided it sounds like the usual sort of thing. In it we find: It draws upon a number of competing perspectives which are rooted in institutional arrangements, social movements and struggles.
Connection linkage to care, treatment and other services. Prevention Individuals can reduce the risk of HIV infection by limiting exposure to risk factors. Key approaches for HIV prevention, which are often used in combination, are listed below. Male and female condom use Correct and consistent use of male and female condoms during vaginal or anal penetration can protect against the spread of sexually transmitted infections, including HIV.
This way people learn of their own infection status and access necessary prevention and treatment services without delay. WHO also recommends offering testing for 28 stories of aids in africa or couples. Additionally, WHO is recommending assisted partner notification approaches so that people with HIV receive support to inform their partners either on their own, or with the help of health care providers.
Testing and counselling, linkages to tuberculosis care Tuberculosis TB is the most common presenting illness and cause of death among people with HIV.
It is fatal if undetected or untreated and is the leading cause of death among people with HIV, responsible for more than 1 of 3 HIV-associated deaths. VMMC is also regarded as a good approach to reach men and adolescent boys who do not often seek health care services.
More than 10 randomized controlled studies have demonstrated the effectiveness of PrEP in reducing HIV transmission among a range of populations including serodiscordant heterosexual couples where one partner is infected and the other is notmen who have sex with men, transgender women, high-risk heterosexual couples, and people who inject drugs.
WHO recommends PEP use for both occupational and non-occupational exposures and for adults and children.
Harm reduction for people who inject and use drugs People who inject drugs can take precautions against becoming infected with HIV by using sterile injecting equipment, including needles and syringes, for each injection and not sharing drug using equipment and drug solutions.
Treatment of dependence, and in particular opioid substitution therapy for people dependent on opioids, also helps reduce the risk of HIV transmission and supports adherence to HIV treatment.
A comprehensive package of interventions for HIV prevention and treatment includes: MTCT can be nearly fully prevented if both the mother and the baby are provided with ARV drugs as early as possible in pregnancy and during the period of breastfeeding.
Several countries with a high burden of HIV infection are also progressing along the path to elimination. ART does not cure HIV infection but suppresses viral replication within a person's body and allows an individual's immune system to strengthen and regain the capacity to fight off infections.
InWHO released the second edition of the Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. These guidelines recommend to provide lifelong ART to all people living with HIV, including children, adolescents and adults, pregnant and breastfeeding women, regardless of clinical status or CD4 cell count.
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection The guidelines include new alternative ARV options with better tolerability, higher efficacy, and lower rates of treatment discontinuation when compared with medicines being used currently: Transition to dolutegravir has already started in 24 low- and middle-income countries and is expected to improve the durability of the treatment and the quality of care of people living with HIV.
Despite improvements, limited options remain for infants and young children. For this reason, WHO and partners are coordinating efforts to enable a faster and more effective development and introduction of age-appropriate pediatric formulations of antiretrovirals.
In addition, 1 in 3 people living with HIV present to care with advanced disease, at low CD4 counts and at high risk of serious illness and death. However, more efforts are needed to scale up treatment, particularly for children and adolescents.“In Stories of AIDS in Africa, Nolen takes the reader on an emotional journey through the continent as she tells the stories of 28 people fighting HIV/AIDS The Reviews: 9.
Buy a cheap copy of Stories of Aids in Africa book by Stephanie Nolen. For the past six years, Stephanie Nolen has traced AIDS across Africa, and 28 is the result: an unprecedented, uniquely human portrait of the continent in 5/5(5). The following table was published in Sept/Oct by the now-defunct Continuum magazine (and I expect elsewhere).
It was part of an article by Christine Johnson, of HEAL Los Angeles. The introduction and list of 64 references from 'HIV' literature are not reproduced here. For the past six years, Stephanie Nolen has traced AIDS across Africa, and 28 is the result: an unprecedented, uniquely human portrait of the continent in crisis.
Through riveting, anecdotal stories, she brings to life men, women, and children involved in every AIDS arena, making them familiar/5(27). Once I read Stories of AIDS in Africa, I was able to understand the origin and transmission of the AIDS virus and the crisis it is causing in Africa.
The author, Stephanie Nolen, through her first hand knowledge of these 28 real life stories, has been able to make me feel as if I am right there beside her listening and feeling the raw. Solving AIDS implies overcoming political, economic and social issues as well as technical issues such as medical breakthroughs.
For example, many poor countries are actively denied access to AIDS drugs or face threats of sanctions from richer nations and their pharmaceutical industry lobbies for trying to produce cheaper generic versions of their medicine.